{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:14:03Z","timestamp":1740107643624,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008001","name":"Universit\u00e4t zu K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00467-021-05136-2","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T21:02:26Z","timestamp":1622926946000},"page":"2961-2966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Commentary on \u201cPediatric Idiopathic Steroid-sensitive Nephrotic Syndrome Diagnosis and Therapy - Short version of the updated German Best Practice Guideline (S2e)\u201d"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3245-7481","authenticated-orcid":false,"given":"Rasmus","family":"Ehren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus R.","family":"Benz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul T.","family":"Brinkk\u00f6tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"D\u00f6tsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang R.","family":"Eberl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Gellermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter F.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Jordans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Kamrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus J.","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Latta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"T\u00f6nshoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the German Society for Pediatric Nephrology","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,5]]},"reference":[{"key":"5136_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","volume":"43","author":"A Pasini","year":"2017","unstructured":"Pasini A, Benetti E, Conti G, Ghio L, Lepore M, Massella L, Molino D, Peruzzi L, Emma F, Fede C, Trivelli A, Maringhini S, Materassi M, Messina G, Montini G, Murer L, Pecoraro C, Pennesi M (2017) The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: part I - diagnosis and treatment of the first episode and the first relapse. Ital J Pediatr 43:41","journal-title":"Ital J Pediatr"},{"key":"5136_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1053\/j.ajkd.2013.12.002","volume":"63","author":"S Samuel","year":"2014","unstructured":"Samuel S, Bitzan M, Zappitelli M, Dart A, Mammen C, Pinsk M, Cybulsky AV, Walsh M, Knoll G, Hladunewich M, Bargman J, Reich H, Humar A, Muirhead N (2014) Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of nephrotic syndrome in children. Am J Kidney Dis 63:354\u2013362","journal-title":"Am J Kidney Dis"},{"key":"5136_CR3","doi-asserted-by":"crossref","unstructured":"(2012) Chapter 3: steroid-sensitive nephrotic syndrome in children. Kidney Int Suppl 2:163-171","DOI":"10.1038\/kisup.2012.16"},{"key":"5136_CR4","doi-asserted-by":"publisher","unstructured":"Schijvens AM, van der Weerd L, van Wijk JAE, Bouts AHM, Keijzer-Veen MG, Dorresteijn EM, Schreuder MF (2021) Practice variations in the management of childhood nephrotic syndrome in the Netherlands. Eur J Pediatr. https:\/\/doi.org\/10.1007\/s00431-021-03958-8","DOI":"10.1007\/s00431-021-03958-8"},{"key":"5136_CR5","doi-asserted-by":"crossref","unstructured":"Samuel SM, Flynn R, Zappitelli M, Dart A, Parekh R, Pinsk M, Mammen C, Wade A, Scott SD; Canadian Childhood Nephrotic Syndrome Project Team* (2017) Factors influencing practice variation in the management of nephrotic syndrome: a qualitative study of pediatric nephrology care providers. CMAJ Open 5:E424-E430","DOI":"10.9778\/cmajo.20160078"},{"key":"5136_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00467-014-2903-7","volume":"30","author":"A Pasini","year":"2015","unstructured":"Pasini A, Aceto G, Ammenti A, Ardissino G, Azzolina V, Bettinelli A, Cama E, Cantatore S, Crisafi A, Conti G, D\u2019Agostino M, Dozza A, Edefonti A, Fede C, Groppali E, Gualeni C, Lavacchini A, Lepore M, Maringhini S, Mariotti P, Materassi M, Mencarelli F, Messina G, Negri A, Piepoli M, Ravaglia F, Simoni A, Spagnoletta L, Montini G, NefroKid Study Group (2015) Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality. Pediatr Nephrol 30:91\u2013101","journal-title":"Pediatr Nephrol"},{"key":"5136_CR7","doi-asserted-by":"publisher","unstructured":"Ehren R, Benz MR, Brinkk\u00f6tter PT, D\u00f6tsch J, Eberl WR, Gellermann J, Hoyer PF, Jordans I, Kamrath C, Kemper MJ, Latta K, M\u00fcller D, Oh J, T\u00f6nshoff B, Weber S, Weber LT (2021) Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy - short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6\/2020. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-021-05135-3","DOI":"10.1007\/s00467-021-05135-3"},{"key":"5136_CR8","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1681\/ASN.2012121200","volume":"24","author":"J Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L, T\u00f6nshoff B, Hoyer P, Querfeld U, Gesellschaft f\u00fcr P\u00e4diatrische Nephrologie (GPN) (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24:1689\u20131697","journal-title":"J Am Soc Nephrol"},{"key":"5136_CR9","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s00467-018-3970-y","volume":"33","author":"U Querfeld","year":"2018","unstructured":"Querfeld U, Weber LT (2018) Mycophenolate mofetil for sustained remission in nephrotic syndrome. Pediatr Nephrol 33:2253\u20132265","journal-title":"Pediatr Nephrol"},{"key":"5136_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/nep.12351","volume":"20","author":"B Wu","year":"2015","unstructured":"Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L (2015) Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. Nephrology (Carlton) 20:18\u201324","journal-title":"Nephrology (Carlton)"},{"key":"5136_CR11","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00467-020-04540-4","volume":"35","author":"P Ravani","year":"2020","unstructured":"Ravani P, Lugani F, Pisani I, Bodria M, Piaggio G, Bartolomeo D, Prunotto M, Ghiggeri GM (2020) Rituximab for very low dose steroid-dependent nephrotic syndrome in children: a randomized controlled study. Pediatr Nephrol 35:1437\u20131444","journal-title":"Pediatr Nephrol"},{"key":"5136_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.kint.2019.09.033","volume":"97","author":"EY-H Chan","year":"2020","unstructured":"Chan EY-H, Webb H, Yu E, Ghiggeri GM, Kemper MJ, Ma AL-T, Yamamura T, Sinha A, Bagga A, Hogan J, Dossier C, Vivarelli M, Liu ID, Kamei K, Ishikura K, Saini P, Tullus K (2020) Both the rituximab dose and maintenance immunosuppression in steroid-dependent\/frequently-relapsing nephrotic syndrome have important effects on outcomes. Kidney Int 97:393\u2013401","journal-title":"Kidney Int"},{"key":"5136_CR13","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","volume":"24","author":"K Kamei","year":"2009","unstructured":"Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M, Saito M, Yoneko M, Iijima K (2009) Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol 24:1321\u20131328","journal-title":"Pediatr Nephrol"},{"key":"5136_CR14","doi-asserted-by":"publisher","unstructured":"Ravani P, Lugani F, Drovandi S, Caridi G, Angeletti A, Ghiggeri GM (2021) Rituximab vs low-dose mycophenolate mofetil in recurrence of steroid-dependent nephrotic syndrome in children and young adults: a randomized clinical trial. JAMA Pediatr. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.6150","DOI":"10.1001\/jamapediatrics.2020.6150"},{"key":"5136_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000045090","volume":"79","author":"R Feneberg","year":"1998","unstructured":"Feneberg R, Schaefer F, Zieger B, Waldherr R, Mehls O, Sch\u00e4rer K (1998) Percutaneous renal biopsy in children: a 27-year experience. Nephron 79:438\u2013446","journal-title":"Nephron"},{"key":"5136_CR16","first-page":"41","volume":"19","author":"MD Sinha","year":"2006","unstructured":"Sinha MD, Lewis MA, Bradbury MG, Webb NJA (2006) Percutaneous real-time ultrasound-guided renal biopsy by automated biopsy gun in children: safety and complications. J Nephrol 19:41\u201344","journal-title":"J Nephrol"},{"key":"5136_CR17","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/BF01727848","volume":"66","author":"J Brodehl","year":"1998","unstructured":"Brodehl J, Brandis M, Helmchen U, Hoyer PF, Burghard R, Ehrich JH, Zimmerhackl RB, Klein W, Wonigeit K (1998) Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Klin Wochenschr 66:1126\u20131137","journal-title":"Klin Wochenschr"},{"key":"5136_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/BF00856658","volume":"5","author":"PF Hoyer","year":"1991","unstructured":"Hoyer PF, Brodehl J, Ehrich JH, Offner G (1991) Practical aspects in the use of cyclosporin in paediatric nephrology. Pediatr Nephrol 5:630\u2013638","journal-title":"Pediatr Nephrol"},{"key":"5136_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/archdischild-2015-308924","volume":"101","author":"N Larkins","year":"2016","unstructured":"Larkins N, Kim S, Craig J, Hodson E (2016) Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children. Arch Dis Child 101:404\u2013408","journal-title":"Arch Dis Child"},{"key":"5136_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5414\/CN109532","volume":"91","author":"J Vogd","year":"2019","unstructured":"Vogd J, Hackl A, Habbig S, Lechner F, Akarkach A, Weber LT, Ehren R (2019) Discontinuation of maintenance therapy in frequently relapsing nephrotic syndrome. Clin Nephrol 91:25\u201331","journal-title":"Clin Nephrol"},{"key":"5136_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00467-018-4071-7","volume":"34","author":"M Yadav","year":"2019","unstructured":"Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A (2019) Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Pediatr Nephrol 34:829\u2013835","journal-title":"Pediatr Nephrol"},{"key":"5136_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1681\/ASN.2012070646","volume":"24","author":"N Teeninga","year":"2013","unstructured":"Teeninga N, Kist-van Holthe JE, van Rijswijk N, de Mos NI, Hop WCJ, Wetzels JFM, van der Heijden AJ, Nauta J (2013) Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol 24:149\u2013159","journal-title":"J Am Soc Nephrol"},{"key":"5136_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.2014.260","volume":"87","author":"N Yoshikawa","year":"2015","unstructured":"Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K, Japanese Study Group of Kidney Disease in Children (2015) A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int 87:225\u2013232","journal-title":"Kidney Int"},{"key":"5136_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2014.240","volume":"87","author":"A Sinha","year":"2015","unstructured":"Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A (2015) Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int 87:217\u2013224","journal-title":"Kidney Int"},{"key":"5136_CR25","first-page":"l1800","volume":"365","author":"W NJA","year":"2019","unstructured":"Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group (2019) Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation. BMJ 365:l1800","journal-title":"BMJ"},{"key":"5136_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.kint.2020.09.024","volume":"99","author":"A Gargiulo","year":"2021","unstructured":"Gargiulo A, Massella L, Ruggiero B, Rav\u00e0 L, Ciofi Degli Atti M, Materassi M, Lugani F, Benetti E, Morello W, Molino D, Mattozzi F, Pennesi M, Maringhini S, Pasini A, Gianoglio B, Pecoraro C, Montini G, Murer L, Ghiggeri GM, Romagnani P, Vivarelli M, Emma F (2021) Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children. Kidney Int 99:475\u2013483","journal-title":"Kidney Int"},{"key":"5136_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2215\/CJN.06140420","volume":"16","author":"D Kainth","year":"2021","unstructured":"Kainth D, Hari P, Sinha A, Pandey S, Bagga A (2021) Short-duration prednisolone in children with nephrotic syndrome relapse: a noninferiority randomized controlled trial. Clin J Am Soc Nephrol 16:225\u2013232","journal-title":"Clin J Am Soc Nephrol"},{"key":"5136_CR28","doi-asserted-by":"publisher","first-page":"e018148","DOI":"10.1136\/bmjopen-2017-018148","volume":"7","author":"AM Schijvens","year":"2017","unstructured":"Schijvens AM, Dorresteijn EM, Roeleveld N, Ter Heine R, van Wijk JAE, Bouts AHM, Keijzer-Veen MG, van de Kar NCAJ, van den Heuvel LPWJ, Schreuder MF (2017) REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study-protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study. BMJ Open 7:e018148","journal-title":"BMJ Open"},{"key":"5136_CR29","doi-asserted-by":"publisher","unstructured":"Sheikh S, Mishra K, Kumar M (2021) Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-021-05048-1","DOI":"10.1007\/s00467-021-05048-1"},{"key":"5136_CR30","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0272-6386(03)00346-9","volume":"41","author":"M Hiraoka","year":"2003","unstructured":"Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, Haruki S, Hayashi S, Ohta K, Momoi T, Ohshima Y, Suganuma N, Mayumi M, West Japan Cooperative Study Group of Kidney Disease in Children (2003) A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children. Am J Kidney Dis 41:1155\u20131162","journal-title":"Am J Kidney Dis"},{"key":"5136_CR31","doi-asserted-by":"crossref","unstructured":"Hahn D, Samuel SM, Willis NS, Craig JC, Hodson EM (2020) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001533.pub6\/full. Accessed 8 December 2020","DOI":"10.1002\/14651858.CD001533.pub6"},{"key":"5136_CR32","doi-asserted-by":"publisher","unstructured":"Christian MT, Maxted AP (2021) Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-021-04985-1","DOI":"10.1007\/s00467-021-04985-1"},{"key":"5136_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00431-017-2891-2","volume":"176","author":"G Desch\u00eanes","year":"2017","unstructured":"Desch\u00eanes G, Vivarelli M, Peruzzi L, ESPN Working Group on Idiopathic Nephrotic Syndrome (2017) Variability of diagnostic criteria and treatment of idiopathic nephrotic syndrome across European countries. Eur J Pediatr 176:647\u2013654","journal-title":"Eur J Pediatr"},{"key":"5136_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00467-018-3929-z","volume":"34","author":"AM Schijvens","year":"2019","unstructured":"Schijvens AM, ter Heine R, de Wildt SN, Schreuder MF (2019) Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome. Pediatr Nephrol 34:389\u2013403","journal-title":"Pediatr Nephrol"},{"key":"5136_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2165\/00128072-200305050-00006","volume":"5","author":"E Hodson","year":"2003","unstructured":"Hodson E (2003) The management of idiopathic nephrotic syndrome in children. Paediatr Drugs 5:335\u2013349","journal-title":"Paediatr Drugs"},{"key":"5136_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/bmj.1.5906.481","volume":"1","author":"AM Davison","year":"1974","unstructured":"Davison AM, Lambie AT, Verth AH, Cash JD (1974) Salt-poor human albumin in management of nephrotic syndrome. Br Med J 1:481\u2013484","journal-title":"Br Med J"},{"key":"5136_CR37","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.91.6.1142","volume":"91","author":"RM Haws","year":"1993","unstructured":"Haws RM, Baum M (1993) Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics 91:1142\u20131146","journal-title":"Pediatrics"},{"key":"5136_CR38","doi-asserted-by":"publisher","first-page":"614535","DOI":"10.3389\/fped.2020.614535","volume":"8","author":"E Serramontmany","year":"2020","unstructured":"Serramontmany E, Mu\u00f1oz M, Fern\u00e1ndez-Polo A, Morillo M, G\u00f3mez-Ganda L, Ca\u00f1ete-Ram\u00edrez C, Ariceta G (2020) Home albumin infusion therapy, another alternative treatment in patients with congenital nephrotic syndrome of the Finnish type. Front Pediatr 8:614535","journal-title":"Front Pediatr"},{"key":"5136_CR39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12098-020-03252-9","volume":"87","author":"J Meena","year":"2020","unstructured":"Meena J, Bagga A (2020) Current perspectives in management of edema in nephrotic syndrome. Indian J Pediatr 87:633\u2013640","journal-title":"Indian J Pediatr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05136-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05136-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05136-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T01:30:24Z","timestamp":1672363824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05136-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,5]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["5136"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05136-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2021,6,5]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RE, MRB, BT, and LTW receive financial support from the BMBF (German Ministry of Education and Research) for the implementation of the INTENT study (EudraCT No. 2014-001991-76). RE, PTB, and LTW receive financial support from the DFG (German Research Foundation) for their work within the Clinical Research Unit 329 (\u201cDisease pathways in podocyte injury \u2013 from molecular mechanisms to individualized treatment options\u201d) at the University Hospital of Cologne.JD is a consultant and expert for Nestl\u00e9 Germany AG, Danone S.A., and Novartis Pharma GmbH (Advisory Board).WRE is a consultant and expert at Bayer AG, Biotest AG, and Sobi AG and has received honoraria for lectures from CSL Behring GmbH, Bayer AG, and Novo Nordisk Pharma GmbH.CK is on the scientific advisory board of BioMarin Pharmaceutical Inc., Aegerion Pharmaceuticals GmbH, and Sobi AG and has received honoraria for lectures and training from Aegerion Pharmaceuticals GmbH and Diurnal Ltd.JO is a consultant and reviewer for Alnylam Germany GmbH and Chiesi GmbH (Advisory Board) and has received lecture fees from Recordati Pharma GmbH.BT is a consultant and expert at Bristol-Myers Squibb GmbH. He is on the scientific advisory board of \u201ctransplant campus\u201d and conducts clinical studies with the companies Novartis Pharma GmbH and Astellas Pharma GmbH.LTW is a consultant and expert for Alexion-Pharma GmbH, Alnylam Germany GmbH, Greenovation Biotech GmbH, and Chiesi GmbH.JG, PFH, IJ, MJK, KL, DM, and SW declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}